Quantitative Systematic Strategies LLC Rigel Pharmaceuticals Inc Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020
SELL
$1.6 - $2.43 $39,073 - $59,343
-24,421 Closed
0 $0
Q3 2019

Nov 07, 2019
SELL
$1.63 - $2.62 $11,854 - $19,055
-7,273 Reduced 22.95%
24,421 $46,000
Q2 2019

Jul 25, 2019
BUY
$2.02 - $2.61 $29,011 - $37,484
14,362 Added 82.86%
31,694 $83,000
Q1 2019

Apr 15, 2019
BUY
$2.0 - $2.65 $34,664 - $45,929
17,332 New
17,332 $45,000

Others Institutions Holding RIGL

# of Institutions
13
Shares Held
355K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.37B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email